# active_site_0077

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **B** — Position 254 (Proton acceptor)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
METVESSSSAELLRAQMHFSTQLFGFHYTAALKCAVKLGIPDAIKQHGKPMNLSELNSALSINPSKAPCIHRLMRILVTAGYFAQENECFSLTSAGRHFLKDDPLNIRALVLLELHPALVKPWIALGEWFQNDDVSPFATAHGKSFWDYVTSDPELRKLFDESMADDSQLIAKALVTEFRYVFEGLKSLVDVGGGSGTLARAIAKAFPNLKCTVCDLPDAVANEHGDGNLDFVAGDMFERVPSADSILLKHILHDWSDEKCVEILKKCREAIPKNGGKVIIVDKLLKNRGHGHAENEHDEATESPLSCDMEMLVLVNGKERDEKEWAKLFSGAGFNDYKYNITPVLGSTSLIEVNFYN

[Multiple Choices]
A. Position 117 (Charge relay)
B. Position 254 (Proton acceptor)
C. Position 205 (For beta-ketoacyl synthase activity)
D. Position 216 (Proton donor)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry, which annotates position 254 as an active-site proton acceptor. This is a ProRule computational annotation, not direct experimental evidence in the supplied record.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence may suggest a methyltransferase fold, but that does not establish which exact residue acts as the proton acceptor.


**Missing item-specific fact**

> The protein-specific annotation identifying residue 254 as the proton acceptor is absent from the question input.


**Reason**

> Distinguishing the exact catalytic position requires protein-specific annotation or experimental knowledge; broad sequence or enzyme-family inference does not determine it.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer evidence supports B specifically; the other listed positions are not annotated as the proton acceptor.


### Important caveats

- The active-site assignment is supported by a computational ProRule annotation, not independently verified experimental evidence here.
- The source sequence matches the benchmark sequence, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence may suggest a methyltransferase fold, but that does not establish which exact residue acts as the proton acceptor.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific annotation identifying residue 254 as the proton acceptor is absent from the question input.",
    "reason": "Distinguishing the exact catalytic position requires protein-specific annotation or experimental knowledge; broad sequence or enzyme-family inference does not determine it."
  },
  "case_id": "active_site_0077",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry, which annotates position 254 as an active-site proton acceptor. This is a ProRule computational annotation, not direct experimental evidence in the supplied record."
  },
  "important_caveats": [
    "The active-site assignment is supported by a computational ProRule annotation, not independently verified experimental evidence here.",
    "The source sequence matches the benchmark sequence, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports B specifically; the other listed positions are not annotated as the proton acceptor."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0077",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry, which annotates position 254 as an active-site proton acceptor. This is a ProRule computational annotation, not direct experimental evidence in the supplied record.",
    "evidence_ids": ["C1", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence may suggest a methyltransferase fold, but that does not establish which exact residue acts as the proton acceptor.",
    "missing_item_specific_fact": "The protein-specific annotation identifying residue 254 as the proton acceptor is absent from the question input.",
    "reason": "Distinguishing the exact catalytic position requires protein-specific annotation or experimental knowledge; broad sequence or enzyme-family inference does not determine it."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports B specifically; the other listed positions are not annotated as the proton acceptor."
  },
  "important_caveats": [
    "The active-site assignment is supported by a computational ProRule annotation, not independently verified experimental evidence here.",
    "The source sequence matches the benchmark sequence, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry D3KYA0 (3-O-methylredipecamine 2-O-methyltransferase IpeOMT3, sequence matched) explicitly annotates position 254 as an Active site with description 'Proton acceptor' (evidence ECO:0000255|PROSITE-ProRule:PRU01020). The residue at position 254 in the supplied sequence is Histidine (H), consistent with the well-established catalytic mechanism of SAM-dependent O-methyltransferases in which a His abstracts a proton from the substrate hydroxyl. The annotation is PROSITE-ProRule (family-pattern-based computational curation), not direct experimental mutagenesis, but it is a well-supported family-level assignment for OMTs.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C1](#evidence-c1), [C4](#evidence-c4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the hallmark SAM-dependent methyltransferase motif 'VLDVGGGSGTLARA' (~positions 190–205), identifying the enzyme as an O-methyltransferase. OMT catalysis proceeds via a His proton acceptor that deprotonates the substrate hydroxyl for nucleophilic methyl transfer from SAM. Among the choices: (A) position 117 is Proline, which cannot participate in a charge relay (a Ser-His-Asp concept from serine proteases); (C) 'beta-ketoacyl synthase activity' refers to a completely different enzyme class (fatty-acid synthase); (D) position 216 is Aspartate, which UniProt annotates as a SAM-binding residue, not a catalytic proton donor in the OMT mechanism. Only (B) pairs a Histidine at position 254 with the correct OMT catalytic role (proton acceptor). Eliminating the three distractors relies on general enzymology knowledge (Pro cannot form charge relays; wrong enzyme class for C; SAM-binding Asp ≠ catalytic proton donor in OMTs).


**Missing item-specific fact**

> Pinpointing position 254 among several histidines in the sequence as THE catalytic His requires structural knowledge of the OMT fold or familiarity with the PROSITE-ProRule pattern, though the distractor-elimination pathway is largely reasoning-accessible.


**Reason**

> The enzyme family is recognizable from the sequence (VLDVGGGSGTLARA SAM-binding motif), and the catalytic mechanism of OMTs (His proton acceptor) is general enzymology. The three distractors are eliminable by basic biological reasoning (Pro in charge relay, wrong enzyme class, SAM-binding residue mislabeled as proton donor). The positive identification of position 254 specifically adds some specificity beyond pure general reasoning, but the elimination logic is strong enough to reach the answer without memorizing this particular UniProt entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Each distractor contains a clear biological error: A assigns a charge relay to Proline; C invokes beta-ketoacyl synthase (wrong enzyme class); D labels a SAM-binding Aspartate as a proton donor. Only B correctly identifies a Histidine as the proton acceptor in an OMT context. No option is defensible besides B.


### Important caveats

- The active-site annotation at position 254 carries evidence code ECO:0000255 (PROSITE-ProRule), i.e., a family-pattern computational assignment, not site-directed mutagenesis or crystallographic catalytic confirmation. It is nonetheless well-supported for the OMT superfamily.
- The question does not state the enzyme identity; the model must infer 'O-methyltransferase' from sequence features (e.g., the VLDVGGGSGTLARA motif) before applying the correct catalytic-mechanism reasoning.
- The UniProt entry was first public in 2025-06-18; the author's source snapshot is unknown, though the sequence has been unchanged since 2010-04-20 (sequence version 1).

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains the hallmark SAM-dependent methyltransferase motif 'VLDVGGGSGTLARA' (~positions 190–205), identifying the enzyme as an O-methyltransferase. OMT catalysis proceeds via a His proton acceptor that deprotonates the substrate hydroxyl for nucleophilic methyl transfer from SAM. Among the choices: (A) position 117 is Proline, which cannot participate in a charge relay (a Ser-His-Asp concept from serine proteases); (C) 'beta-ketoacyl synthase activity' refers to a completely different enzyme class (fatty-acid synthase); (D) position 216 is Aspartate, which UniProt annotates as a SAM-binding residue, not a catalytic proton donor in the OMT mechanism. Only (B) pairs a Histidine at position 254 with the correct OMT catalytic role (proton acceptor). Eliminating the three distractors relies on general enzymology knowledge (Pro cannot form charge relays; wrong enzyme class for C; SAM-binding Asp ≠ catalytic proton donor in OMTs).",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Pinpointing position 254 among several histidines in the sequence as THE catalytic His requires structural knowledge of the OMT fold or familiarity with the PROSITE-ProRule pattern, though the distractor-elimination pathway is largely reasoning-accessible.",
    "reason": "The enzyme family is recognizable from the sequence (VLDVGGGSGTLARA SAM-binding motif), and the catalytic mechanism of OMTs (His proton acceptor) is general enzymology. The three distractors are eliminable by basic biological reasoning (Pro in charge relay, wrong enzyme class, SAM-binding residue mislabeled as proton donor). The positive identification of position 254 specifically adds some specificity beyond pure general reasoning, but the elimination logic is strong enough to reach the answer without memorizing this particular UniProt entry."
  },
  "case_id": "active_site_0077",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C1",
      "C4"
    ],
    "judgment": "supported",
    "reason": "UniProt entry D3KYA0 (3-O-methylredipecamine 2-O-methyltransferase IpeOMT3, sequence matched) explicitly annotates position 254 as an Active site with description 'Proton acceptor' (evidence ECO:0000255|PROSITE-ProRule:PRU01020). The residue at position 254 in the supplied sequence is Histidine (H), consistent with the well-established catalytic mechanism of SAM-dependent O-methyltransferases in which a His abstracts a proton from the substrate hydroxyl. The annotation is PROSITE-ProRule (family-pattern-based computational curation), not direct experimental mutagenesis, but it is a well-supported family-level assignment for OMTs."
  },
  "important_caveats": [
    "The active-site annotation at position 254 carries evidence code ECO:0000255 (PROSITE-ProRule), i.e., a family-pattern computational assignment, not site-directed mutagenesis or crystallographic catalytic confirmation. It is nonetheless well-supported for the OMT superfamily.",
    "The question does not state the enzyme identity; the model must infer 'O-methyltransferase' from sequence features (e.g., the VLDVGGGSGTLARA motif) before applying the correct catalytic-mechanism reasoning.",
    "The UniProt entry was first public in 2025-06-18; the author's source snapshot is unknown, though the sequence has been unchanged since 2010-04-20 (sequence version 1)."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Each distractor contains a clear biological error: A assigns a charge relay to Proline; C invokes beta-ketoacyl synthase (wrong enzyme class); D labels a SAM-binding Aspartate as a proton donor. Only B correctly identifies a Histidine as the proton acceptor in an OMT context. No option is defensible besides B."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0077",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry D3KYA0 (3-O-methylredipecamine 2-O-methyltransferase IpeOMT3, sequence matched) explicitly annotates position 254 as an Active site with description 'Proton acceptor' (evidence ECO:0000255|PROSITE-ProRule:PRU01020). The residue at position 254 in the supplied sequence is Histidine (H), consistent with the well-established catalytic mechanism of SAM-dependent O-methyltransferases in which a His abstracts a proton from the substrate hydroxyl. The annotation is PROSITE-ProRule (family-pattern-based computational curation), not direct experimental mutagenesis, but it is a well-supported family-level assignment for OMTs.",
    "evidence_ids": ["C5", "H3", "C1", "C4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the hallmark SAM-dependent methyltransferase motif 'VLDVGGGSGTLARA' (~positions 190–205), identifying the enzyme as an O-methyltransferase. OMT catalysis proceeds via a His proton acceptor that deprotonates the substrate hydroxyl for nucleophilic methyl transfer from SAM. Among the choices: (A) position 117 is Proline, which cannot participate in a charge relay (a Ser-His-Asp concept from serine proteases); (C) 'beta-ketoacyl synthase activity' refers to a completely different enzyme class (fatty-acid synthase); (D) position 216 is Aspartate, which UniProt annotates as a SAM-binding residue, not a catalytic proton donor in the OMT mechanism. Only (B) pairs a Histidine at position 254 with the correct OMT catalytic role (proton acceptor). Eliminating the three distractors relies on general enzymology knowledge (Pro cannot form charge relays; wrong enzyme class for C; SAM-binding Asp ≠ catalytic proton donor in OMTs).",
    "missing_item_specific_fact": "Pinpointing position 254 among several histidines in the sequence as THE catalytic His requires structural knowledge of the OMT fold or familiarity with the PROSITE-ProRule pattern, though the distractor-elimination pathway is largely reasoning-accessible.",
    "reason": "The enzyme family is recognizable from the sequence (VLDVGGGSGTLARA SAM-binding motif), and the catalytic mechanism of OMTs (His proton acceptor) is general enzymology. The three distractors are eliminable by basic biological reasoning (Pro in charge relay, wrong enzyme class, SAM-binding residue mislabeled as proton donor). The positive identification of position 254 specifically adds some specificity beyond pure general reasoning, but the elimination logic is strong enough to reach the answer without memorizing this particular UniProt entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Each distractor contains a clear biological error: A assigns a charge relay to Proline; C invokes beta-ketoacyl synthase (wrong enzyme class); D labels a SAM-binding Aspartate as a proton donor. Only B correctly identifies a Histidine as the proton acceptor in an OMT context. No option is defensible besides B."
  },
  "important_caveats": [
    "The active-site annotation at position 254 carries evidence code ECO:0000255 (PROSITE-ProRule), i.e., a family-pattern computational assignment, not site-directed mutagenesis or crystallographic catalytic confirmation. It is nonetheless well-supported for the OMT superfamily.",
    "The question does not state the enzyme identity; the model must infer 'O-methyltransferase' from sequence features (e.g., the VLDVGGGSGTLARA motif) before applying the correct catalytic-mechanism reasoning.",
    "The UniProt entry was first public in 2025-06-18; the author's source snapshot is unknown, though the sequence has been unchanged since 2010-04-20 (sequence version 1)."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `D3KYA0` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 55. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/D3KYA0.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:05.017010+00:00.  

```json
"D3KYA0"
```

Source SHA-256: `8911ef7ad13ac56e9c6773425d0a513fcd7261f04f5d354fbd82723603276578`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/D3KYA0.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:05.017010+00:00.  

```json
{"alternativeNames":[{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"20061395","source":"PubMed"}],"value":"2.1.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"20061395","source":"PubMed"}],"value":"(S)-norreticuline 7-O-methyltransferase IpeOMT1"}},{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"20061395","source":"PubMed"}],"value":"2.1.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"20061395","source":"PubMed"}],"value":"Ipecac/benzylisoquinoline alkaloid O-methyltransferase 3"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"20061395","source":"PubMed"},{"evidenceCode":"ECO:0000312","id":"BAI79245.1","source":"EMBL"}],"value":"IpeOMT3"}]}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"20061395","source":"PubMed"}],"value":"2.1.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"20061395","source":"PubMed"}],"value":"3-O-methylredipecamine 2-O-methyltransferase IpeOMT3"}}}
```

Source SHA-256: `8911ef7ad13ac56e9c6773425d0a513fcd7261f04f5d354fbd82723603276578`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/D3KYA0.json)  
**Locator:** `/features/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:25:05.017010+00:00.  

```json
{"description":"Proton acceptor","evidences":[{"evidenceCode":"ECO:0000255","id":"PRU01020","source":"PROSITE-ProRule"}],"location":{"end":{"modifier":"EXACT","value":254},"start":{"modifier":"EXACT","value":254}},"type":"Active site"}
```

Source SHA-256: `8911ef7ad13ac56e9c6773425d0a513fcd7261f04f5d354fbd82723603276578`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/D3KYA0?format=txt&versions=55)  
**Locator:** `lines 110-112`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 55 / 1.  
**Retrieved:** 2026-11-01T06:27:56.691295+00:00.  

```text
FT   ACT_SITE        254
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01020"
```

Source SHA-256: `b2752ed70781d19baf56582001780d450973cdc5bdf7404b99bcf5d3ef0488be`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 77. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
